NCT06360081View on ClinicalTrials.gov

A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 15, 2024

Conditions
Healthy
Interventions
DRUG

Zongertinib manufacturer 1

Zongertinib

DRUG

Zongertinib manufacturer 2

Zongertinib

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY